Today, the U.S. Food and Drug Administration announced it has awarded 11 new clinical trial research grants, equaling more than $25 million of funding over the next four years. The FDA’s Congressionally-funded Orphan Products Grants Program awards these grants to clinical investigators to support the development of medical products for patients with rare diseases.
FDA awards 11 grants to clinical trials to develop new medical products for rare disease treatments
October 14, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022